Development and psychometric properties of the HPV Impact Profile (HIP) to assess the psychosocial burden of HPV
- PMID: 19739938
- DOI: 10.1185/03007990903238786
Development and psychometric properties of the HPV Impact Profile (HIP) to assess the psychosocial burden of HPV
Abstract
Objective: A comprehensive questionnaire designed to assess the full spectrum of potential human papillomavirus (HPV)-related psychosocial effects in women does not exist. The HPV Impact Profile (HIP) was developed to determine the psychosocial impact of HPV infection and related interventions.
Research design and methods: Draft instrument items and domains were developed using a literature review and cognitive debriefing interviews with women who had experienced HPV-related conditions. An importance rating questionnaire guided item ranking and reduction. A draft questionnaire was pilot-tested for comprehension and ease of completion. Psychometric evaluation of the final HIP was conducted in a survey of 583 women. Data quality, item acceptability, scale acceptability, reliability, and discriminate construct validity were assessed.
Outcome measure: The final HIP contained 29 items rated on a 0-10 point discretized visual analog scales grouped into seven hypothesized domains.
Results: Total HIP scores ranged from 0 (no impact) to 100 (worst impact). Data quality was high, with missing data for items ranging from 0 to 0.7% and over 99% of the scores were computable. Cronbach's alpha ranged from 0.64 to 0.90 and was > or =0.7 for 5/7 domains. Discriminant construct validity was demonstrated. Appropriate modifications could potentially be made to improve some aspects of the HIP, including modification to include other HPV diseases such as head and neck, anal, and vulvovaginal cancers and HPV disease in men.
Conclusions: The disease-specific HIP has favorable reliability and construct validity and a good ability to discriminate among disease severity.
Similar articles
-
The psychological impact of illness among women experiencing human papillomavirus-related illness or screening interventions.J Psychosom Obstet Gynaecol. 2010 Mar;31(1):16-23. doi: 10.3109/01674820903564440. J Psychosom Obstet Gynaecol. 2010. PMID: 20121461
-
Development and psychometric evaluation of the ICIQ Vaginal Symptoms Questionnaire: the ICIQ-VS.BJOG. 2006 Jun;113(6):700-12. doi: 10.1111/j.1471-0528.2006.00938.x. BJOG. 2006. PMID: 16709214
-
The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease.Br J Dermatol. 2007 Mar;156(3):528-38. doi: 10.1111/j.1365-2133.2006.07617.x. Br J Dermatol. 2007. PMID: 17300244
-
The development of measures of community capacity for community-based funding programs in Canada.Health Promot Int. 2007 Dec;22(4):299-306. doi: 10.1093/heapro/dam024. Epub 2007 Oct 17. Health Promot Int. 2007. PMID: 17942594 Review.
-
Essential elements of questionnaire design and development.J Clin Nurs. 2007 Feb;16(2):234-43. doi: 10.1111/j.1365-2702.2006.01573.x. J Clin Nurs. 2007. PMID: 17239058 Review.
Cited by
-
Health-related quality of life and psychosocial impacts of a diagnosis of non-specific genital infection in symptomatic heterosexual men attending UK sexual health clinics: a feasibility study.BMJ Open. 2018 Jun 30;8(6):e018213. doi: 10.1136/bmjopen-2017-018213. BMJ Open. 2018. PMID: 29960999 Free PMC article.
-
Estimating the burden of illness related to genital warts in the Philippines: a nationally representative cross-sectional study.Infect Agent Cancer. 2019 Oct 7;14:26. doi: 10.1186/s13027-019-0240-y. eCollection 2019. Infect Agent Cancer. 2019. PMID: 31624494 Free PMC article.
-
Measuring the psychosocial burden in women with low-grade abnormal cervical cytology in the TOMBOLA trial: psychometric properties of the Process and Outcome Specific Measure (POSM).Health Qual Life Outcomes. 2014;12:154. doi: 10.1186/s12955-014-0154-8. Health Qual Life Outcomes. 2014. PMID: 25767846 Free PMC article.
-
HPV knowledge and impact of genital warts on self esteem and sexual life in Colombian patients.BMC Public Health. 2013 Mar 25;13:272. doi: 10.1186/1471-2458-13-272. BMC Public Health. 2013. PMID: 23530591 Free PMC article.
-
Durability of response to VGX-3100 treatment of HPV16/18 positive cervical HSIL.Hum Vaccin Immunother. 2021 May 4;17(5):1288-1293. doi: 10.1080/21645515.2020.1823778. Epub 2020 Nov 11. Hum Vaccin Immunother. 2021. PMID: 33175656 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources